Positive Topline Results From Phase 3 ATTR-ACT Study of Tafamidis in Patients With Transthyretin Cardiomyopathy

Positive Topline Results From Phase 3 ATTR-ACT Study of Tafamidis in Patients With Transthyretin Cardiomyopathy

Commentaires

Articles les plus consultés